38
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Autologous Bone Marrow Transplantation in Adult Patients with Acute Lymphoblastic Leukemia

, , &
Pages 9-14 | Published online: 01 Jul 2009

  • Linker, C.A., Levitt, L.J., O'Donnel, M., et al. (1991) "Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report", Blood 78, 2814-2822.
  • Butturini, A. and Gale, R.P. (1989) "How can we cure leukaemia?", British Journal of Haematoloy 72, 479-485.
  • Hoelzer, D., Thiel, E., Loffler, H., et al. (1988) "Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults", Blood 71, 123-131.
  • McGovern, Jr. J.J., Russell, P.S., Atkins, L. and Webster, E.W. (1959) "Treatment of terminal leukemic relapse by total-body irradiation and intraveneous infusion of stored autologous bone marrow obtained during remission", New England Journal of Medicine 260, 675-683.
  • Blume, K.G. and Thomas, E.D. (2000) "A review of autologous hematopoietic cell transplantation", Biology and Blood Marrow Transplantation 6, 1-12.
  • Dicke, K.A., Zander, A., Spitzer, G., et al. (1979) "Autologous bone marrow transplantation in relapsed adult acute leukemia", The Lancet 1, 514-517.
  • Gorin, N.C. (1998) "Autologous stem cell transplantation in acute myelocytic leukemia", Blood 92, 1073-1090.
  • Koerbling, M., Hunstein, W., Fliedner, T.M., et al. (1989) "Disease-free survival after autologus bone marrow transplantation in patients with acute myelogenous leukemia", Blood 74, 1898-1904.
  • Cassileh, P.A., Anderson, J., Lazarus, H.M., et al. (1993) "Autologous bone marrow transplant in acute myeloid leukemia in first remission", Journal of Clinical Oncology 11. 314-319.
  • Linker, C.A., Ries, C.A., Damon, L.E., et al. (1998) "Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide purged bone marrow and the busulfan-etoposide preparative regimen: a follow-up report", Bone Marrow Transplantation 22, 865-872.
  • Yeager, A.M., Kaizer, H., Santos, G.W., et al. (1986) "Autologous bone marrow transplantation in patients with 4-hydroperoxycyclophosphamide", New England Journal of Medicine 315, 141-147.
  • [12] Zittoun, R.A., Mandelli, F., Willemze, R., et al. (1995) "Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo ltaliano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups", New England Journal of Medicine 332, 217-223.
  • Burnett, A.K., Goldstone, A.H., Stevens, R.M.F., et al. (1998) "Randomised comparison of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC-AML 10 trial", The Lancet 351,700-708.
  • Goekbuget, N., Hoelzer, D., Arnold, R., et al. (2000) "Treatment of adult ALL according to the protocols of the German Multicenter Study Group for Adult ALL (GMALL)", Hematology-Oncology Clinics of North America 14, 1307-1325.
  • Billet, A.L. and Sallan, S.E. (1993) "Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use ofpurging", American Journal of Pediatric hematology Oncology 15,162-168.
  • Maldonado, M.S., Diaz-Heredia, C., BadeII, I., et al. (1998) "Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission. Spanish Working Party for BMT in Children", Bone Marrow Transplantation 22, 1043-1047.
  • Kersey, J.H., Weisdorf, D., Nesbit, M.E., et al. (1987) "Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia", New England Journal of Medicine 317, 461-467.
  • Kersey, J., Weisdorf, D., Uckun, F., et al. (1992) "Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia", Leukemia 6(Suppl. 2), 191-192.
  • McMillan, A.K., Goldstone, A.H., Chopra, R, and Linch, D.C. (1990) "A comparison of the outcome of ABMT in first remission acute myeloid and lymphoblastic leukemia in a single center", Bone Marrow Transplantation 6(Suppl. 1), 72.
  • Koerbling, M., Knauf, W., Funderud, S., et al. (1991) "Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia", Haematologica 76(Suppl. 1 ), 29-36.
  • Arcese, W., Amadori, S., Meloni, G., et al. (1991) "Allogeneic or autologous bone marrow transplanta-tion for intensification of salvage therapy in patients with high-risk advanced acute lympho-blastic leukemia. The AIEOP/GIMEMA Groups", Seminars in Hematology 28(Suppl. 4), 116-121.
  • Cahn, J.Y., Flesch, M., Vemant, J.P. and Fiere, D. (1992) "Autologous bone marrow transplantation for intensification of first remission in adult patients with acute lymphoblastic leukemia",Leukemia 6(Suppl. 4), 100-102.
  • Bernasconi, C., Lazzarino, M., Morra, F., et al. (1992) "Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study", Leukemia 6(Suppl. 2), 204-208.
  • Doney, K., Buckner, C.D., Fisher, L., et al. (1993) "Autologous bone marrow transplantation for acute lymphoblastic leukemia", Bone marrow Transplantation 12, 315-321.
  • Abdallah, A., Egerer, G., Goldschmidt, H., et al. (2001) "Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow", British Journal of Haematology 112, 1012-1015.
  • European Bone Marrow Transplant Group-EBMTG(1995) "Working party on acute leukemia", Annual Report.
  • Ramsay, N.K. and Kersey, J.H. (1988) "Bone marrow purging using monoclonal antibodies", Journal of Clinical Immunology 8, 81-88.
  • Sebban, C., Lepage, E., Vernant, J.P., Gluckman, E., Attal, M., Reiffers, J., Sutton, L., Racadot, E., Michatlet, M., Maraninchi, D., et al. (1994) "Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of therapy of Adult Acute Lymphoblastic Leukemia", Journal of Clinical Oncology 12, 2580-2587.
  • Kaizer, H., Stuart, R.K., Brookmeyer, R., et al. (1985) "Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells", Blood 65, 1504-1510.
  • Douay, L., Mary, J.Y., Giarratana, M.C., et al. (1989) "Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557)", Experimental Hematology 17,429-432.
  • Gulliya, K.S. and Matthews, J. L., (1988) "Photosensitization of leukemic cells and normal bone marrow cells by nm laster light and effects of laser light on migration inhibition and lymphokine response", Cell Biology International Report 12, 305-312.
  • Bast, B.J., Cooper, M.D. and Kearney, J.F. (1984) "Cellular expression of idiotopes defined by monoclonal antibodies", European Journal of Immunology 14, 623-628.
  • Kvalheim, G., Sorenson, O., Fodstad, O., et al. (1988) "Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use", Bone Marrow Transplantation 3, 31-41.
  • Strong, R. C., Uckun, F., Youle, R.J., et al. (1985) "Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation", Blood 66, 627-635.
  • Uckun, F.M., Kersey, J.H., Waddick, K.G. and Ramsay, N.K.C. (1988) "Residual acute lymphoblastic leukemia blasts in autologous remission marrow grafts", Journal of Cellular Biochemistry 12C,124.
  • Atta, J., Fauth, F., Keyser, M., Petershofen, E., Weber, C., Lippok,G., Hoelzer, D. and Martin, H. (2000) "Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction", Bone Marrow Transplantation 25,97-104.
  • Blume, K.G., Long, G.D., Negrin, R.S., et al (1994) "Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation", Bone Marrow Transplantation 14(Suppl. 4), S9-S10, Review.
  • Sierra, J., Granena, A., Garcia, J., Valls, A., Carreras, E., Rovira, M., Canals, C., Martinez, E., Punti, C., Algara, M., et al. (1993) "Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients", Bone Marrow Transplantation 12, 517-523.
  • Weisdorf, D.J., Billet, A.L., Hannan, P., et al. (1997) "Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia", Blood 90, 2962-2968.
  • Soiffer, R.J., Roy, D.C., Goinim R., et al. (1993) "Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse", Bone Marrow Transplantation 12, 243-251.
  • Granena, A., Castellsague, X., Badell, I., et al. (1999) "Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement", Bone Marrow Trans-plantation 24, 621-627.
  • Horowitz, M.M., Messerer, D., Hoelzer, D., Gale, R.P., Neiss, A., Atkinson, K., Barrett, A.J., Buchner, T., Freund, M., Heil, G., et al.(1991) "Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission", Annals of Internal Medicine 115, 13-18.
  • Fiere, D., Lepage, E., Sebban, C., et al. (1993) "Adult acute lymphoblastic leukemia: A multicenter randomized trial testing bone marrow transplantation as postremission therapy", Journal of Clinical Oncology 11, 1990-2001.
  • Hoelzer, D., Thiel, E., LÖffler, H., et al. (1994) "Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults", Blood 64, 38-47.
  • Czuczman, M.S., Dodge, R.K., Stewart, C.C., Frankel, S.R., Davey, F.R., Powell, B.L., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. and Bloomfield, CD. (1999) "Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364", Blood, 3931-3939.
  • Bloomfield, C.D., Secker-Walker, L.M., Goldman, A.I., Van Den Berghe, H., de la Chapelle, A., Ruutu, T., Alimena, G., Garson, O.M., Golomb, H.M., Rowley, J.D., et al. (1989) "Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia", Cancer Genetics and Cytogentics 40, 171-185.
  • Faderl, S., Kantarjian, H.M., Talpaz, M. and Estrov, Z. (1998) "Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia", Blood 91, 3995-4019.
  • Hoelzer, D. (1992) "Prognostic factors in acute lymphoblastic leukemia", Leukemia 6(Suppl. 4), 49-51.
  • Ottmann, O.G. and Hoelzer, D. (2002) "The tyrosine ABL kinase inhibitor ST1571 (GIivec) in Philadelphia-positive acute lymphoblastic leukemia-promises, pitfalls and possibilities", Hematology Journal 3, 2-6.
  • Druker, B.J., Sawyers, C.L., Kantarjian, H., et al. (2001) "Activity of a specific inhibitor of the BCR-ABL lyrosine kinase in the blast crisis of chronich myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", New England Journal of Medicine 344, 1038-1042.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.